VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Cancer. 2016 09 01; 122(17):2671-9.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Pancreatic Ductal
Chemoradiotherapy
Chemotherapy, Adjuvant
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Pancreatic Neoplasms
Pancreaticoduodenectomy
Preoperative Care
Prognosis
Prospective Studies
Retrospective Studies
Survival Rate
authors with profiles
ROBERT A WOLFF
JASON B FLEMING
GAURI R VARADHACHARY
SUNIL KRISHNAN
MICHAEL JAMES OVERMAN
PRAJNAN DAS
MATTHEW HAROLD KATZ
MILIND JAVLE
DAVID FOGELMAN
RACHNA SHROFF
EUGENE JON KOAY
ANIRBAN MAITRA